Table 1 Demographic and clinical features of patients with systemic lupus erythematosus.

From: Risk factors of diffuse alveolar hemorrhage in Chinese patients with systemic lupus erythematosus

Characteristics

Non-DAH group (n = 896)

DAH group (n = 47)

p

N (%)

Mean ± SD

Quartile

N (%)

Mean ± SD

Quartile

Age (year)

 

37.7 ± 15.9

(26.0, 48.8)

 

31.8 ± 13.7

(22.0, 41.0)

0.014

Sex

       

Female

789 (88.1)

  

42 (89.4)

  

0.788

SLE duration(year)

 

3.3 ± 5.2

(0.2, 5.0)

 

1.9 ± 3.3

(0.1, 2.0)

0.004

Malar rash

279 (31.1)

  

12 (25.5)

  

0.417

Epilepsy

15 (1.7)

  

5 (10.6)

  

< 0.001

Neuropsychological involvement

84 (9.4)

  

8 (17.0)

  

0.142

Fever

301 (33.6)

  

25 (53.2)

  

0.006

Arthritis

422 (47.1)

  

24 (51.1)

  

0.596

Photosensitivity

113 (12.6)

  

2 (4.3)

  

0.088

Serositis

252 (28.1)

  

32 (68.1)

  

< 0.001

Xerostomia/xeroma

93 (10.4)

  

3 (6.4)

  

0.525

Oral ulcer

100 (11.2)

  

14 (29.8)

  

< 0.001

Raynaud’s phenomenon

103 (11.5)

  

4 (8.5)

  

0.529

Alopecia

161 (8.0)

  

15 (31.9)

  

0.017

Rash

251 (28.0)

  

15 (31.9)

  

0.562

Pulmonary hypertension

286 (31.9)

  

24 (51.1)

  

0.006

ILD

75 (8.4)

  

9 (19.2)

  

0.023

SLEDAI

      

< 0.001

0–4

303 (33.8)

  

2 (4.3)

   

5–9

328 (36.6)

  

11 (23.4)

   

10–14

154 (17.2)

  

12 (25.5)

   

≥ 15

111 (12.4)

  

22 (46.8)

   

Pathogen infection

299 (33.4)

  

39 (83.0)

  

< 0.001

  1. SLE, systemic lupus erythematosus; ILD, interstitial lung disease; SLEDAI, systemic lupus erythematosus disease activity index.